Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1985 May;85(1):21–27. doi: 10.1111/j.1476-5381.1985.tb08826.x

Synergistic interaction between histamine and ouabain on ventricular fibrillation threshold.

J P Trzeciakowski
PMCID: PMC1916752  PMID: 2862939

Abstract

The interaction between histamine and ouabain on the ventricular fibrillation threshold (VFT) was studied in the isolated, Langendorff-perfused heart of the guinea-pig. When administered separately, histamine and ouabain each reduced the VFT in a concentration-related manner with ED50 values of 84.3 and 250 nM, respectively. When perfused in combination the effects of these two drugs on VFT were significantly greater than the sum of their individual contributions. Mepyramine and cimetidine both antagonized the fibrillatory effects of the histamine-ouabain combination. Neither antagonist affected the fibrillation concentration-response curve for ouabain. These results suggest that both classes of histamine receptor may participate in the histamine-ouabain interaction.

Full text

PDF
21

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARIENS E. J., SIMONIS A. M., VAN ROSSUM J. M. A theoretical basis of molecular pharmacology. III. Interaction of one or two compounds with two independent receptor systems. Arzneimittelforschung. 1956 Dec;6(12):737–746. [PubMed] [Google Scholar]
  2. Almotrefi A. A., Baker J. B. The antifibrillatory potency of aprindine, mexiletine, tocainide and lignocaine compared on Langendorff-perfused hearts of rabbits and guinea-pigs. J Pharm Pharmacol. 1980 Nov;32(11):746–750. doi: 10.1111/j.2042-7158.1980.tb13059.x. [DOI] [PubMed] [Google Scholar]
  3. Blandina P., Barattini M., Fantozzi R., Masini E., Mannaioni P. F. Histamine release by vagal stimulation. Agents Actions. 1983 Apr;13(2-3):179–182. doi: 10.1007/BF01967326. [DOI] [PubMed] [Google Scholar]
  4. Cranefield P. F. Action potentials, afterpotentials, and arrhythmias. Circ Res. 1977 Oct;41(4):415–423. doi: 10.1161/01.res.41.4.415. [DOI] [PubMed] [Google Scholar]
  5. Euler D. E. Release of autonomic neuromediators by local ventricular electrical stimulation. Am J Physiol. 1980 Jun;238(6):H794–H800. doi: 10.1152/ajpheart.1980.238.6.H794. [DOI] [PubMed] [Google Scholar]
  6. Feigen G. A., Prager D. J. Experimental cardiac anaphylaxis. Physiologic, pharmacologic and biochemical aspects of immune reactions in the isolated heart. Am J Cardiol. 1969 Oct;24(4):474–491. doi: 10.1016/0002-9149(69)90490-1. [DOI] [PubMed] [Google Scholar]
  7. French A. M., Scott N. C. The effects of a benzotriazinium salt on ventricular fibrillation in the guinea-pig perfused isolated heart [proceedings]. Br J Pharmacol. 1978 Jun;63(2):379P–379P. [PMC free article] [PubMed] [Google Scholar]
  8. Gross S. S., Guo Z. G., Levi R., Bailey W. H., Chenouda A. A. Release of histamine by sympathetic nerve stimulation in the guinea pig heart and modulation of adrenergic responses. A physiological role for cardiac histamine? Circ Res. 1984 May;54(5):516–526. doi: 10.1161/01.res.54.5.516. [DOI] [PubMed] [Google Scholar]
  9. Hashimoto K., Moe G. K. Transient depolarizations induced by acetylstrophanthidin in specialized tissue of dog atrium and ventricle. Circ Res. 1973 May;32(5):618–624. doi: 10.1161/01.res.32.5.618. [DOI] [PubMed] [Google Scholar]
  10. Inui J., Imamura H. Restoration by histamine of the calcium-dependent electrical and mechanical response in the guinea-pig papillary muscle partially depolarized by potassium. Naunyn Schmiedebergs Arch Pharmacol. 1976 Sep;294(3):261–269. doi: 10.1007/BF00508394. [DOI] [PubMed] [Google Scholar]
  11. Levi R., Capurro N. Cardiac histamine-ouabain interaction: potentiation by ouabain of the arrhythmogenic effects of histamine. J Pharmacol Exp Ther. 1975 Jan;192(1):113–119. [PubMed] [Google Scholar]
  12. Levi R., Chenouda A. A., Trzeciakowski J. P., Guo Z. G., Aaronson L. M., Luskind R. D., Lee C. H., Gay W. A., Subramanian V. A., McCabe J. C. Dysrhythmias caused by histamine release in guinea pig and human hearts. Klin Wochenschr. 1982 Sep 1;60(17):965–971. doi: 10.1007/BF01716956. [DOI] [PubMed] [Google Scholar]
  13. Levi R. Effects of exogenous and immunologically released histamine on the isolated heart: a quantitative comparison. J Pharmacol Exp Ther. 1972 Aug;182(2):227–238. [PubMed] [Google Scholar]
  14. Levi R., Malm J. R., Bowman F. O., Rosen M. R. The arrhythmogenic actions of histamine on human atrial fibers. Circ Res. 1981 Aug;49(2):545–550. doi: 10.1161/01.res.49.2.545. [DOI] [PubMed] [Google Scholar]
  15. Levi R., Zavecz J. H. Acceleration of idioventricular rhythms by histamine in guinea pig heart: mediation by H2 receptors. Circ Res. 1979 Jun;44(6):847–855. doi: 10.1161/01.res.44.6.847. [DOI] [PubMed] [Google Scholar]
  16. Lorenz W. Histamine release in man. Agents Actions. 1975 Dec;5(5):402–416. doi: 10.1007/BF01972656. [DOI] [PubMed] [Google Scholar]
  17. Marshall R. J., Muir A. W., Winslow E. Comparative antidysrhythmic and haemodynamic effects of orally or intravenously administered mexiletine and ORG 6001 in the anaesthetized rat. Br J Pharmacol. 1981 Oct;74(2):381–388. doi: 10.1111/j.1476-5381.1981.tb09982.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Opie L. H., Thandroyen F. T. Calcium antagonists, ventricular fibrillation, and enzyme release in ischemic rat hearts. Fed Proc. 1983 May 15;42(8):2465–2469. [PubMed] [Google Scholar]
  19. Pöch G., Holzmann S. Quantitative estimation of overadditive and underadditive drug effects by means of theoretical, additive dose-response curves. J Pharmacol Methods. 1980 Sep;4(2):179–188. doi: 10.1016/0160-5402(80)90036-4. [DOI] [PubMed] [Google Scholar]
  20. Rosen M. R., Gelband H., Merker C., Hoffman B. F. Mechanisms of digitalis toxicity. Effects of ouabain on phase four of canine Purkinje fiber transmembrane potentials. Circulation. 1973 Apr;47(4):681–689. doi: 10.1161/01.cir.47.4.681. [DOI] [PubMed] [Google Scholar]
  21. Senges J., Randolf U., Katus H. Ventricular arrhythmias in cardiac anaphylaxis. Naunyn Schmiedebergs Arch Pharmacol. 1977 Nov;300(2):115–121. doi: 10.1007/BF00505041. [DOI] [PubMed] [Google Scholar]
  22. Smith T. W., Antman E. M., Friedman P. L., Blatt C. M., Marsh J. D. Digitalis glycosides: mechanisms and manifestations of toxicity. Part II. Prog Cardiovasc Dis. 1984 May-Jun;26(6):495–540. doi: 10.1016/0033-0620(84)90014-8. [DOI] [PubMed] [Google Scholar]
  23. Somberg J. C., Bounous H., Cagin N., Levitt B. Histamine antagonists as antiarrhythmic agents in ouabain cardiotoxicity in the cat. J Pharmacol Exp Ther. 1980 Aug;214(2):375–380. [PubMed] [Google Scholar]
  24. Sperelakis N. Cyclic AMP and phosphorylation in regulation of Ca++ influx into myocardial cells and blockade by calcium antagonistic drugs. Am Heart J. 1984 Feb;107(2):347–357. doi: 10.1016/0002-8703(84)90385-5. [DOI] [PubMed] [Google Scholar]
  25. Tanz R., Opie L. Effect of drug or electrically induced tachyarrhythmias on the release of lactate dehydrogenase (LDH) in isolated perfused guinea-pig hearts. I. Comparison of the effects produced by ouabain, calcium, epinephrine and aconitine. J Pharmacol Exp Ther. 1978 Aug;206(2):320–330. [PubMed] [Google Scholar]
  26. Trzeciakowski J. P., Levi R. Reduction of ventricular fibrillation threshold by histamine: resolution into separate H1- and H2-mediated components. J Pharmacol Exp Ther. 1982 Dec;223(3):774–783. [PubMed] [Google Scholar]
  27. VASSALLE M., KARIS J., HOFFMAN B. F. Toxic effects of ouabain on Purkinje fibers and ventricular muscle fibers. Am J Physiol. 1962 Sep;203:433–439. doi: 10.1152/ajplegacy.1962.203.3.433. [DOI] [PubMed] [Google Scholar]
  28. WEIDMANN S. Effects of calcium ions and local anesthetics on electrical properties of Purkinje fibres. J Physiol. 1955 Sep 28;129(3):568–582. doi: 10.1113/jphysiol.1955.sp005379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. WILLIAMS E. M., SZEKERES L. A comparison of tests for antifibrillatory action. Br J Pharmacol Chemother. 1961 Dec;17:424–432. doi: 10.1111/j.1476-5381.1961.tb01129.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Winkle R. A., Jaillon P., Griffin J. C., Schnittger I. Time dependency of ventricular fibrillation thresholds determined using trains of stimuli. Am J Physiol. 1980 Oct;239(4):H457–H463. doi: 10.1152/ajpheart.1980.239.4.H457. [DOI] [PubMed] [Google Scholar]
  31. Winslow E. Methods for the detection and assessment of antiarrhythmic activity. Pharmacol Ther. 1984;24(3):401–433. doi: 10.1016/0163-7258(84)90011-1. [DOI] [PubMed] [Google Scholar]
  32. Yao L. F., MacLeod K. M., McNeill J. H. Ca2+ dependence of positive inotropic responses of guinea pig isolated cardiac preparations to cAMP-generating and cAMP-independent agonists. Can J Physiol Pharmacol. 1984 Jan;62(1):105–108. doi: 10.1139/y84-017. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES